How GLP-1 Medications Are Revolutionizing Weight Loss
- Michael From The GLP-1 Source
- Nov 8, 2024
- 3 min read
Updated: Mar 5

Understanding Weight Loss Challenges
Many people struggle with weight loss despite consistent dieting and exercise. Often, weight loss progress is temporary, with lost weight quickly regained. Research indicates that these challenges can stem from differences in metabolic rates and other health factors that impact weight regulation. For some, medication may be an effective addition to their weight loss strategy.
What are Semaglutide and GLP-1?
Semaglutide, an injectable medication, gained FDA approval in 2021 for chronic weight management, particularly in individuals who are overweight or obese. This medication, marketed under the name Wegovy®, is part of a class known as GLP-1 receptor agonists (GLP-1 RAs). Originally developed as a treatment for type 2 diabetes, GLP-1 RAs like semaglutide have proven effective for weight loss as well.
The Role of GLP-1 in the Body
GLP-1, or glucagon-like peptide-1, is a hormone that plays a key role in insulin production and appetite regulation. When released in response to food intake, GLP-1 stimulates insulin production, helping to control blood sugar levels. It also impacts areas in the brain responsible for appetite, signaling satiety and fullness.
Because of these effects, GLP-1 medications can support weight loss by reducing hunger and controlling blood sugar, especially when combined with lifestyle changes like diet and exercise.
The Effectiveness of Semaglutide for Weight Loss
Numerous studies show that semaglutide is effective in aiding significant weight loss. A 2021 study published in the New England Journal of Medicine examined 2,000 adults with obesity, split into two groups: one using semaglutide alongside diet and exercise, and another using only lifestyle changes. After 68 weeks, participants using semaglutide experienced an average weight loss of 15%, with about one-third of participants achieving a 20% reduction in body weight. In contrast, the group following lifestyle changes alone saw only a 2.4% decrease in body weight.

These findings underscore the potential of semaglutide to support meaningful weight loss, which may lower risks associated with obesity, such as diabetes, heart disease, and certain cancers.
Long-Term Considerations of GLP-1 Use
While GLP-1 medications like semaglutide have shown effectiveness in weight management, they are not without limitations. Studies suggest that individuals often regain lost weight if they discontinue use, indicating the importance of sustained lifestyle changes and potentially ongoing treatment.
Off-Label Uses of GLP-1 Medications
Although Wegovy® is the only FDA-approved GLP-1 medication specifically for weight loss, other brands such as Ozempic® and Rybelsus® are sometimes prescribed "off-label" for weight management. This means they are used for weight loss even though their FDA approval is for diabetes treatment. The interest in these medications continues to grow as they demonstrate promising results in weight management.
Conclusion
GLP-1 medications, particularly semaglutide, have introduced a new approach to weight loss, offering support for those who may not achieve desired results with lifestyle changes alone. While these medications are not suitable for everyone, they represent an important development in the field of weight management, helping many people achieve substantial weight loss and improve their health.
Continued research will provide further insights into long-term effectiveness, optimal usage, and potential challenges associated with these treatments

Comments